Skip to main content
Caplight Logo









SineuGene Therapeutics

SineuGene Therapeutics

Private
BeijingHealthcare & Life Scienceshttps://sineugene.com/

Last Round

VC Round

Aug 1, 2024

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SineuGene Therapeutics is a biopharmaceutical company that develops innovative gene therapy treatments for neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVantisense oligonucleotideASOneurodegenerative diseasebiotechALS treatmentgene delivery platformclinical-stage biotechdrug discoveryprecision medicinegenetic medicinebiopharmaclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SineuGene Therapeutics Comparables

Compare SineuGene Therapeutics with similar companies based on industry and business-model similarity.

SineuGene Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avrion Therapeutics AG
88%
AviadoBio
80%
Trace Neuroscience
79%

SineuGene Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 1, 2024
AngelJan 18, 2023
SeedMar 1, 2022

SineuGene Therapeutics Investors

Notable investors and investment history

SineuGene Therapeutics investors
InvestorRounds
Zhongbo JuliVC Round
MSA CapitalAngel
Zhongguancun CapitalVC Round
Transfar CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 35% MoM, reaching 2.6K.

  • Mar 3, 2026

    Monthly visitors increased 44% MoM.

SineuGene Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SineuGene Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SineuGene Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range2
Year Founded2021
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?